HERPHEGEN
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

HERPHEGEN Trademark

Serial Number: 79262917 • Registration: 6077138

HERPHEGEN is a trademark filed by The Secretary of State for Health and Social Care on February 22, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 39 (Transportation & Storage), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

Trademark Details

Filing Date

February 22, 2019

Registration Date

June 16, 2020

Published for Opposition

March 31, 2020

Goods & Services

Education, namely, providing both online and in-person classes, seminars, and workshops in the fields of healthcare, antiviral resistance, antiviral testing and database interpretation and management; providing of training in the fields of healthcare, antiviral resistance, antiviral testing and database interpretation and management; teaching in the fields of healthcare, antiviral resistance, antiviral testing and database interpretation and management; arranging and conducting of conferences, seminars and training workshops for educational purposes; Education in the fields of healthcare, antiviral resistance, antiviral testing and database interpretation and management rendered through correspondence courses; vocational guidance; organisation of exhibitions for educational purposes; Providing on-line non-downloadable publications in the nature of educational course materials, newsletters, reports, journals, studies and evaluations relating to healthcare, antiviral resistance, antiviral testing and database interpretation and management

Transport, packaging and storage of goods; transport of DNA samples; packaging and storage of DNA samples; storage of micro-organisms, bacteria and cultures of micro-organisms and bacteria

Pharmaceutical preparations for diagnosing and treating herpes virus infections; diagnostic preparations and substances for medical purposes; diagnostic preparations and substances for medical purposes and all for in vivo use; cultures for medical use; micro-organisms, bacteria and cultures and preparations of micro-organisms for medical and veterinary use; media for bacteriological cultures; nutritive substances for micro-organisms for medical purposes; chemical preparations for use in DNA analysis for medical purposes

Database management; database marketing; computerized database management; compilation of information into computer databases

Chemicals for use in science; biological preparations for use in science; chemical products and substances for in vitro use for use in industry and science; micro-organisms, cultures and preparations of micro-organisms for laboratory use and for scientific, research and testing purposes, other than for medical use; reagent kits comprising generic DNA circle, DNA primers, polymerase and buffers for use in biotechnology research purposes; Enzymes for laboratory use and for scientific, research and testing purposes, for use in the continuous homogenous isothermal amplifications of specific DNA templates; agar and glycerol for the storage of micro-organisms and bacteria

Medical services; veterinary services; health care; hospital services and medical clinics; medical assistance; nursing services; medical and healthcare services relating to DNA, genetics and genetic testing, genetics and genetic testing

Research services, namely, medical research, pharmaceutical research and scientific research; research and development services, namely, medical, pharmaceutical and scientific research and development services; consultancy services in the field of research and development, namely, medical research and medical product development, pharmaceutical research and development, scientific research and development; dissemination of information in the field of scientific research and development, all relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, immunology, pharmacology, and health matters; scientific consultancy services relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, immunology, pharmacology, and health; laboratory analysis, laboratory research and laboratory testing services; scientific consultancy services relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, bioterrorism, immunology, pharmacology or health matters; providing scientific research information relating to biological, microbiological, microbial, genetic, chromosomal, environmental, biosafety, bioterrorism, immunology, pharmacology or health matters; clinical research services, namely, collection of clinical data for scientific, medical and pharmaceutical research purposes; DNA screening for scientific research purposes

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 16, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 28, 2020 FINO
GENERIC MADRID TRANSACTION SENT TO IB
Oct 6, 2020 XXSS
GENERIC MADRID TRANSACTION CREATED
Oct 5, 2020 XXCR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 16, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 16, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 31, 2020 NPUB
PUBLISHED FOR OPPOSITION
Mar 31, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 11, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 27, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Feb 26, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Feb 26, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Feb 26, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Feb 26, 2020 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 26, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 26, 2020 CRFA
ASSIGNED TO LIE
Feb 25, 2020 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 20, 2020 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 20, 2020 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 20, 2020 CHAN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Feb 20, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Feb 20, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 20, 2020 COAR
ASSIGNED TO EXAMINER
Nov 12, 2019 DOCK
REFUSAL PROCESSED BY IB
Sep 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 21, 2019 RFCS
REFUSAL PROCESSED BY MPU
Aug 21, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 25, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 24, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 20, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 16, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2019 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 11, 2019 REPR